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Abstract
Background: Microglia migrate during brain development and after CNS injury, but it is not known how they degrade
the extracellular matrix (ECM) to accomplish this. Podosomes are tiny structures with the unique ability to adhere to
and dissolve ECM. Podosomes have a two-part architecture: a core that is rich in F-actin and actin-regulatory molecules
(for example, Arp2/3), surrounded by a ring with adhesion and structural proteins (for example, talin, vinculin). We
recently discovered that the lamellum at the leading edge of migrating microglia contains a large F-actin-rich
superstructure (‘podonut’) composed of many podosomes. Microglia that expressed podosomes could degrade ECM
molecules. Finely tuned Ca2+ signaling is important for cell migration, cell-substrate adhesion and contraction of the
actomyosin network. Here, we hypothesized that podosomes contain Ca2+-signaling machinery, and that podosome
expression and function depend on Ca2+ influx and specific ion channels.
Methods: High-resolution immunocytochemistry was used on rat microglia to identify podosomes and novel
molecular components. A pharmacological toolbox was applied to functional assays. We analyzed roles of Ca2+-entry
pathways and ion channels in podosome expression, microglial migration into a scratch-wound, transmigration
through pores in a filter, and invasion through Matrigel™-coated filters.
Results: Microglial podosomes were identified using well-known components of the core (F-actin, Arp2) and ring (talin,
vinculin). We discovered four novel podosome components related to Ca2+ signaling. The core contained calcium
release activated calcium (CRAC; Orai1) channels, calmodulin, small-conductance Ca2+-activated SK3 channels, and
ionized Ca2+ binding adapter molecule 1 (Iba1), which is used to identify microglia in the CNS. The Orai1 accessory
molecule, STIM1, was also present in and around podosomes. Podosome formation was inhibited by removing external
Ca2+ or blocking CRAC channels. Blockers of CRAC channels inhibited migration and invasion, and SK3 inhibition
reduced invasion.
Conclusions: Microglia podosome formation, migration and/or invasion require Ca2+ influx, CRAC, and SK3 channels.
Both channels were present in microglial podosomes along with the Ca2+-regulated molecules, calmodulin, Iba1 and
STIM1. These results suggest that the podosome is a hub for sub-cellular Ca2+-signaling to regulate ECM degradation
and cell migration. The findings have broad implications for understanding migration mechanisms of cells that adhere
to, and dissolve ECM.
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Introduction
In the healthy adult CNS, microglia constantly survey
the environment, extending and retracting their ramified
processes, but without overall cell displacement [1,2].
Microglia migrate during the perinatal period of devel-
opment, and after acute injury in the adult, they activate
and move to the damage site (reviewed in [3-5]). In gen-
eral, cell migration requires cleavage of cell-cell or cell-
matrix interactions [6]. Little is known about how
microglia navigate through the densely packed brain tis-
sue with its unique extracellular matrix (ECM). Outside
the CNS, two related structures identified in several cell
types have the unique ability to both adhere to and de-
grade ECM molecules. Podosomes (non-cancer cells)
and invadopodia (cancer cells) differ from other cell ad-
hesion structures in this dual functionality, and in their
composition, architecture and dynamics (recently reviewed
in [7-9]).
We recently found that in microglia, the lamellum at
the leading edge contains many podosomes that spon-
taneously organize into super-structures we call ‘podonuts’
[10]. Microglial podosomes express several hallmark fea-
tures of podosomes in other cells. They are tiny (<1 μm
diameter) punctate structures at the ventral cell surface,
with F-actin in the core surrounded by a ring of the plaque
protein, talin. Microglial podosomes are also enriched in
phosphotyrosine residues, and in three tyrosine-kinase
regulated molecules that have only been reported in a few
cell types. These are Tks5 (tyrosine kinase substrate with
five Src homology 3 domains), tyrosine phosphorylated
caveolin-1, and nicotinamide adenine dinucleotide phos-
phate oxidase 1 (Nox1) [10]. Microglia that expressed
podonuts were able to degrade the ECM components,
fibronectin and Matrigel™. Thus, these structures can po-
tentially aid in migration through brain tissue. Despite
their molecular complexity, podosomes are highly dynamic
with lifetimes of 2 to 20 minutes [8,11]. However,
mechanisms that regulate their rapid turnover are not well
understood.
Ca2+ entry regulates several processes involved in cell
migration, including cell-substrate adhesion and con-
traction of the actomyosin network [12,13]. In immune
cells, store-operated Ca2+ entry is predominantly mediated
by Orai1, which is the pore-forming subunit of the
Ca2+-release activated Ca2+ (CRAC) channel [14,15]. We
previously characterized the CRAC current in rat microglia.
It is activated by store depletion, highly selective for Ca2+,
and is strongly inward-rectifying, which results in much
greater Ca2+ influx at hyperpolarized membrane potentials
[16,17]. In non-excitable cells, including microglia, small-
conductance Ca2+-activated K+ (SK) channels are well
designed to respond to a slight elevation in intracellular
Ca2+ and maintain a hyperpolarized membrane potential.
SK channel opening does not require depolarization.
Instead, they open when Ca2+ (Kd 200 to 800 nM)
[18,19] interacts with calmodulin that is bound to the
channel’s proximal C-terminus [20-22]. We previously
showed that rat microglia express SK3 (KCa2.3/KCNN3)
and SK4 (IK1/KCa3.1/KCNN4) channels. Both channels
contribute to lipopolysaccharide-induced microglial ac-
tivation (through p38 MAPK) and their consequent
ability to kill neurons [23,24]. Of note, we observed that
SK3 expression increased in activated microglia that
had migrated into stroke lesions in vivo [24]. Therefore,
we examined whether microglial podosomes contain
SK3 and its obligatory subunit, calmodulin. Then, we
conducted experiments to test the hypothesis that podo-
some formation and microglial migration are regulated by
Ca2+ entry through CRAC channels. Based on the results,
we further hypothesized that podosomes contain Orai1




All procedures on animals were approved by the Univer-
sity Health Network Animal Care Committee, in accord-
ance with guidelines from the Canadian Council on
Animal Care. Microglia cultures were prepared from
1- to 2 day-old Sprague–Dawley rat pups (Charles River,
St.-Constant, PQ, Canada) using our standard protocols,
which yield ≥99% purity [23,24]. In brief, after removal
of the meninges, the brain was dissected, minced in cold
Minimal Essential Medium (MEM; Invitrogen, Carlsbad,
CA, USA), centrifuged (300 × g, 10 min) and re-
suspended in MEM supplemented with 10% fetal bovine
serum (FBS; Wisent, St-Bruno, PQ, Canada), and 0.05
mg/ml gentamycin (Invitrogen). The dissociated cells
were then seeded in 75 cm2 flasks and incubated at 37°C
and 5% CO2. After 48 hr, the medium was replaced with
fresh medium to remove cellular debris and non-
adherent cells, and after a further 4 to 5 days in mixed
culture, microglia were harvested by shaking the flasks
for 2 to 4 hr on an orbital shaker at 65 rpm (37°C, 5%
CO2). After centrifuging the microglia-rich supernatant
(300 × g, 10 min), the cell pellet was re-suspended in fresh
MEM (with 2% FBS), and seeded onto UV-irradiated 15
mm glass coverslips (Fisher Scientific, Ottawa, ON,
Canada) at 50,000 or 60,000 cells per coverslip in 12-well
plates, and cultured for 1 to 2 days in MEM (2% FBS).
Importantly, we find that under these growth conditions,
their starting state is relatively resting [25].
Roles of Ca2+ entry in podosome formation
Isolated microglia were cultured for 24 to 48 hr and
then the tissue culture medium was replaced with stand-
ard bath solution containing (in mM): 125 NaCl, 5 KCl,
1 MgCl2, 1 CaCl2, 5 D-glucose and 10 HEPES, and
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adjusted to pH 7.4 with NaOH. The osmolarity was
measured with an Advanced Micro Osmometer (Model
3300; Advanced Instruments Inc, Norwood, MA, USA),
and adjusted to 285 to 300 mOsm with 0.5 to 2 g/l su-
crose. Five channel inhibitors were tested. Stock solu-
tions in DMSO were made for 2-APB (2-aminoethyl
diphenylborinate; Sigma-Aldrich, St. Louis, MO, USA),
BTP2 (N-{4-[3,5-bis(trifluoromethyl)-1H-pyrazol-1-yl]
phenyl}-4-methyl-1,2,3-thiadiazole-5-carboxamide; EMD
Millipore Calbiochem, San Diego, CA, USA) and NS8593
(Sigma-Aldrich). Stock solutions in ddH2O were made for
gadolinium (III) chloride (GdCl3; Sigma-Aldrich) and
spermine tetrahydrochloride (EMD Millipore Calbiochem).
For Ca2+-free bath solutions (0 Ca2+), the tissue culture
medium was replaced with standard bath solution lacking
CaCl2 and with 1 mM ethyleneglycol-bis(β-aminoethyl)-N,
N,N’,N’-tetraacetic acid (EGTA). Control cells were main-
tained in standard bath solution under identical experi-
mental conditions. Bath solutions were sterilized by
filtering through 0.2 μm filters, and all treatments were
performed at 37°C for 30 min. Before fixing treated cells
for immunocytochemistry, cells were washed once with
sterile phosphate-buffered saline (PBS). Large rings of
podosomes (podonuts) were counted from three random
fields of cells on each cover slip, and averaged over several
microglia cultures prepared from different animals.
Immunocytochemistry and cell labeling
The methods were similar to our recent paper [10].
Microglia were seeded at 50,000 to 60,000/glass cover
slip and cultured for 2 to 3 days in MEM with 2% FBS.
They were then fixed in 4% paraformaldehyde (Electron
Microscopy Sciences, Hatfield, PA, USA) at room
temperature for 15 min. The cells were permeabilized
with 0.2% Triton X-100 for 5 min and washed in PBS
(3×, 5 min each). Non-specific antigens were blocked
with 4% donkey serum for 1 hr. All antibodies (Table 1)
were diluted in 2.5% donkey serum and centrifuged be-
fore use (8200 × g, 10 min) to precipitate any aggregated
antibody. Microglia were incubated with one or two pri-
mary antibodies overnight at 4°C, washed (3×, 5 min
each) and blocked with 4% donkey serum for 1 hr. They
were incubated with an anti-rabbit, anti-mouse or anti-
goat secondary antibody (all raised in donkey) for at
least 1 hr, and then washed (3×, 10 min each). Negative
controls were prepared using the same protocol, but
omitting each primary antibody. We previously validated
the SK3 antibody by comparing staining in SK3-free
CHO cells versus those transfected with SK3 [24]. The
other primary antibodies have all been used in the litera-
ture and assumed to be specific. F-actin was visualized
by incubating the cells (15 min, room temperature) with
Alexa Fluor™ 488-conjugated phalloidin (1:50 in blocking
solution, Invitrogen). Occasionally, microglia were co-
labeled with FITC-conjugated tomato lectin (Sigma-
Aldrich), which binds to N-acetyl-lactosamine residues
on the microglia surface [26]. In this case, after applying
secondary antibody and washing, microglia were incu-
bated with tomato lectin (1:500 in PBS with 2.5% donkey
serum; 15 min, room temperature) and then processed as
described above. Cell nuclei were labeled with 4’,6-dia-
midino-2-phenylindole (DAPI; 1:3000 in PBS, 5 min;
Invitrogen). After washing (3×, 5 min each), cells on
coverslips were mounted on glass slides with 50% gly-
cerol in PBS (which produced the lowest background),
VectaShield™ (Vector Labs, Burlington, CA, USA) or
Dako mounting medium (Dako, Glostrup, Denmark).
Dako mounting medium yielded more stable signals for
longer imaging (Z-stacks). For Orai1 and CaM staining,
we used an antigen retrieval step after fixation. Cover slips
were microwaved on medium power for 3 min in citrate
buffer, cooled in buffer and washed with PBS. Antigen re-
trieval is used to unmask epitopes that are obscured by
crosslinking [27].
Images were acquired with an Axioplan 2 wide field
epifluorescence microscope equipped with an Axiocam
HRm digital camera, and were analyzed with Axiovision
4.6 software (all from Zeiss, Toronto, ON, Canada) or
ImageJ [28]. For many images, we acquired Z-stacks of
high-magnification epifluorescence images through the
entire cell in 200 nm increments. These images were
deconvolved using a theoretical point spread function
and the constrained iterative maximum likelihood algo-
rithm in Axiovision 4.7 software (Zeiss). Deconvolution
reduces noise and distortions introduced during image
acquisition. It uses information about the optical system
(for example, type of objective lens, refractory index of the
immersion medium) to calculate a point spread function
of light above and below the plane of focus (reviewed
in [29]). Cell auto-fluorescence and non-specific staining
were subtracted by using the same imaging and acquisi-
tion settings on cells exposed to a secondary antibody
alone. When constructing Z-stacks, the automated cor-
rection algorithm was used to compensate for fluores-
cence decay during repeated exposures.
Migration, substrate degradation and invasion assays
Live imaging
Microglia were plated at 60,000 cells/dish in 35 mm glass
bottom culture dishes (MatTek Corporation, Ashland, MA,
USA), and cultured for 2 days in MEM with 2% FBS. Cells
were imaged for up to 1 hr using a Zeiss Axiovert 200M
microscope, ORCA-ER camera (Hamamatsu Corporation,
Bridgewater, NJ, USA), Axiovision software (Zeiss) and
Neue LiveCell™ stage top incubator (Pathology Devices,
Westminster, MD, USA) to maintain a temperature of 37°C
and 5% CO2.
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Scratch wound
Microglia were seeded at 50,000 to 60,000 cells per 15
mm glass cover slip, and cultured in MEM with 2% FBS
until approximately 80% confluent (1 to 2 days). The
resulting monolayer of microglia was scratched with a
sterile 200 μl pipette tip, with or without addition of a
channel blocker (50 μM 2-APB, 5 μM GdCl3, 10 μM
BTP2). The cells were incubated for 24 hr (37°C, 5%
CO2), fixed and permeabilized as described above
(Immunochemical analysis), and stained with FITC-
conjugated tomato lectin (1:500, 15 min; Sigma) and
DAPI (1:3000 in PBS, 5 min). Five random fields along
the border of the scratch were imaged at 10× magnifica-
tion using a confocal microscope (LSM 510 META; Carl
Zeiss, Jena, Germany) and saved. The number of micro-
glia infiltrating into the wound was quantified by count-
ing all the tomato lectin-positive cells within the scratch
region. At least five individual cultures were used to cal-
culate the mean migration, and results were normalized
to control (untreated) microglia.
Transmigration
Microglia were suspended in MEM containing 2% FBS, and
150 μl of cell suspension (2×104 cells) was added to the
upper well of each Transwell™ insert (VWR, Mississauga,
ON, Canada), which bore an uncoated filter with 8
μm-diameter holes. The lower well contained only the
medium (MEM with 2% FBS). After 30 min, a channel in-
hibitor (50 μM 2-APB, 5 μM GdCl3, 10 μM BTP2, 7 μM
NS8593) was added to the upper well, and then incubated
for 24 hr (37°C, 5% CO2). The remaining microglia on the
upper side were removed with a Q-tip™. To quantify
the number of microglia that had transmigrated to the
underside, the filter was fixed in 4% paraformaldehyde,
rinsed with PBS, stained with 0.3% crystal violet for 1
min, and again rinsed with PBS. Microglia on the under-
side of each filter were counted in five fields of view per
filter at 40× magnification using an Olympus CK2
inverted microscope (Olympus, Tokyo, Japan). At least
three individual cultures were used, and results were
normalized to control (untreated) microglia.
Substrate degradation
The standard assay for studying ECM degradation by
podosomes (and invadopodia) employs fluorescent-
labeled substrate (usually fibronectin or gelatin), either
coated directly on glass coverslips or on a layer of gel-
atin. ECM degradation is then monitored as loss of sub-
strate fluorescence. We labeled bovine fibronectin
(Sigma-Aldrich, Oakville, ON, Canada) using the Alexa
Fluor™ 488 Protein Labeling Kit (Invitrogen), after which
the conjugated protein was separated from unconjugated
dye on a column. Purified, labeled fibronectin was diluted
in PBS (approximately 2 μg/ml), added to glass cover slips
(150 μl/cover slip) and incubated overnight at 37°C. After
the solution was aspirated off, microglia were seeded onto
the fibronectin-coated cover slips (50,000 cells/cover slip)
and incubated for 24 hr. Fixation and staining then
proceeded as described above (Immunocytochemistry and
cell labeling).
Invasion
Microglial invasion through a basement membrane type of
ECM (Matrigel™, which is secreted by mouse sarcoma
cells) was quantified using 24-well BioCoat Matrigel™ In-
vasion Chambers (BD Biosciences, Mississauga, ON,
Table 1 Antibodies
Primary antibodies (species and type) Dilution Supplier
α-Tubulin (mouse monoclonal) 1:1000 Abcam (Cambridge, MA, USA)
Arp2 (rabbit polyclonal) 1:100 Santa Cruz Biotechnology (Santa Cruz, CA, USA)
CaM (rabbit monoclonal or mouse monoclonal) 1:200 Abcam
Iba-1 (rabbit polyclonal) 1:1000 Wako Chemicals (Richmond, VA, USA)
Orai-1 (goat polyclonal) 1:100 Santa Cruz Biotechnology
SK3 (rabbit polyclonal) 1:200 Alomone (Jerusalem, Israel)
STIM1 (rabbit polyclonal) 1:100 Sigma-Aldrich (St. Louis, MO, USA)
Talin1/2 (mouse monoclonal) 1:100 Abcam
TRPM7 (goat polyclonal) 1:200 Santa Cruz Biotechnology
Vimentin (mouse monoclonal) 1:1000 Millipore (Billerica, MA, USA)
Vinculin (mouse monoclonal) 1:200 Sigma-Aldrich
Secondary antibodies
DyLight 488 or 594 (donkey anti-rabbit) 1:500 Jackson Immunoresearch (West Grove, PA, USA)
DyLight 488 or 594 (donkey anti-mouse) 1:500 Jackson Immunoresearch
DyLight 488 (donkey anti-goat) 1:500 Jackson Immunoresearch
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Canada). The filters, which had 8 μm-diameter holes
coated with Matrigel™, were rehydrated for 1 hr at 37°C
with 500 μl of medium (MEM, 2% FBS), which was then
replaced with 500 μl of fresh MEM (with 2% FBS) con-
taining 2×104 microglia. The lower well of each cham-
ber contained 500 μl of medium only (MEM, 2% FBS).
After 30 min, microglia were treated with a channel in-
hibitor (50 μM 2-APB, 5 μM GdCl3, 10 μM BTP2, 7 μM
NS8593) and then incubated (24 hr, 37°C, 5% CO2),
and prepared and counted as above (Transmigration).
At least three individual cultures were used to calculate
the mean invasion, and results were normalized to con-
trol (untreated) microglia.
Statistical analysis
Quantitative data are presented as mean ± standard
error of the mean (S.E.M). One-way analysis of variance
was followed by post-hoc Tukey’s test, and results are
considered significant if P < 0.05.
Results
Microglial podosomes contain three Ca2+-regulated
molecules not previously reported
Live-cell imaging confirmed that under the conditions in
the present study, migrating microglia have a lamellum at
the leading edge and a uropod at the rear (Figure 1A). We
recently showed that each lamellum usually contains a
large, donut-shaped, F-actin rich structure (‘podonut’)
comprised of many individual podosomes [10]. Podosomes
are typically recognized as a talin-rich ring surrounding a
core of F-actin [7,8]. Here, we made the surprising disco-
very that the small-conductance Ca2+-activated K+ chan-
nel, SK3, is enriched at the leading edge of migrating
microglia. SK3 was often in a single large ring in the lamel-
lum (Figure 1B), and coincident with F-actin (Figure 1C).
High-resolution deconvolution imaging of the podonut
ring shows SK3 in individual podosomes (punctae <1 μm
diameter), surrounded by talin (Figure 1D).
The standard test of podosome functionality is degrad-
ation of a fluorescent-labeled substrate (usually fibronectin
or gelatin), which is seen as a loss of fluorescence [11,30].
The ECM component, fibronectin is not normally in the
brain parenchyma, but can enter after injury [31,32]. We
recently found that microglia podosomes degrade fibro-
nectin and Matrigel™ [10]. Here, we show that when
microglia were plated onto fluorescent-labeled fibronectin,
its degradation could produce podonut-sized regions of
reduced fluorescence (Figure 1E). Punctae of fibronectin
degradation were similar to the tiny podosome-sized
punctae of SK3 and F-actin (Figure 1F). [Note: The optical
resolution of this in situ zymography is lower than for
immunocytochemistry of cells plated on glass.]
CaM is essential for normal functioning of SK chan-
nels, acting as both the Ca2+ sensor and gate for channel
opening [20,22]. Podosomes are at the ventral cell sur-
face, and we previously discovered that CaM is required
for surface membrane expression of SK4 channels [33].
This was later shown for SK2 [34] and SK3 [35]. In the
healthy adult brain, CaM expression is low in microglia
but is elevated in activated microglia after damage [36],
when they are expected to be migratory. We hypothe-
sized that CaM will be highly expressed in migrating
microglia and present in the podosome. Western blot-
ting showed that CaM is highly expressed in cultured,
migratory rat microglia (Figure 2A). Immunostaining
showed enriched CaM immunoreactivity in the podonut
(Figure 2B), and co-localization with robust staining for
the podosome marker, talin (Figure 2C). At high magni-
fication, CaM was seen both adjacent to and over-
lapping with the podosome core marker, Arp2
(Figure 2D). Not surprisingly, CaM co-localized with
SK3 in podonuts in microglia lamellae (Figure 2E). [Note
that antigen retrieval was necessary for CaM immuno-
cytochemistry; see Methods.]
In the CNS, ionized Ca2+ adapter molecule 1 (Iba1) is
commonly used as a microglia-specific marker [37,38].
Because Iba1 is an actin-cross linking protein, we asked
whether it is associated with the cytoskeleton, and specif-
ically with podosomes. Iba1 was enriched in the podonut
but did not co-localize with vimentin, which projected
into the lamellum and uropod (Figure 3A). Vimentin is a
major cytoskeletal component in microglia [39]. In podo-
nuts, Iba1 was highly co-localized with F-actin (Figure 3B;
yellow in the merged image). As expected, the podosome
ring marker, talin was highly enriched in podonuts
(Figure 3C). High-resolution, deconvolved images showed
podosome-sized punctae of Iba1 (<1 μm diameter) sur-
rounded by talin (Figure 3C’).
Podosome formation is regulated by Ca2+ entry, likely
through Orai1/CRAC channels
Podosomes continually turn over, with a reported lifetime
of 2 to 20 min [8]. We next addressed whether microglial
podosomes depend on a specific route of Ca2+ entry. The
number of cells bearing a podonut was quantified after in-
cubation (30 min, 37°C) in bath solution with or without
compounds known to affect Ca2+ entry in these cells.
Microglia were fixed at 30 min and podonuts were visua-
lized by staining for F-actin and talin. Representative
images are shown in Figure 4A to 4F, and the proportion
of cells with a podonut is summarized in Figure 4G.
Omitting external Ca2+ reduced podonut prevalence
by more than tenfold: from 10.9 ± 1.2% of cells in con-
trol solution (Figure 4A,G) to 1.0 ± 0.2% in Ca2+-free so-
lution (Figure 4B,G). The broad-spectrum Ca2+ channel
blocker, 5 μM Gd3+, decreased podonut prevalence to a
similar degree: to 0.7 ± 0.2% of cells (Figure 4C,G). Rat
microglia express several Ca2+-permeable transient








A SK3   TL 
DAPI
B
merge + DAPI SK3 fibronectinE
SK3 F-actinF
fibronectin
SK3  fibronectinSK3 F-actin
SK3
talin DAPI
Figure 1 (See legend on next page.)
Siddiqui et al. Journal of Neuroinflammation 2012, 9:250 Page 6 of 16
http://www.jneuroinflammation.com/content/9/1/250
receptor potential (TRP) channels, including TRP mela-
statin 7 (TRPM7) [17,40]. TRPM7 can be blocked by
2-APB ([17]; and see Discussion), and we found that 50
μM 2-APB nearly abolished podonuts (0.2 ± 0.2% of
cells; Figure 4D,G). Importantly, this concentration of
2-APB also blocks the highly Ca2+-selective CRAC chan-
nel produced by the pore-forming subunit, Orai1. We
previously showed that CRAC is a major component of
store-operated Ca2+ entry (SOCE) in rat microglia, and
is effectively blocked by 2-APB without toxicity [17].
Therefore, we next tested BTP2, a more selective CRAC
channel blocker with reported IC50 values ranging from
0.1 to 2.2 μM [41,42]. At 10 μM, BTP2 decreased podo-
nut prevalence to 3.5 ± 1.0% of cells (Figure 4E,G). At 1
μM, there was no inhibition by BTP2 (data not shown).
This result rules out the main potential side effect of
BTP2. That is, Ca2+-entry through TRPM4 channels in
lymphocytes was enhanced by low nanomolar concen-
trations of BTP2 (IC50 approximately 100-fold lower
than for CRAC) [42]. This was a concern because
TRPM4 is expressed in murine microglia [43]. Finally, to
further distinguish between CRAC and TRPM7 chan-
nels, we applied spermine. We previously showed that
the concentration used effectively blocks TRPM7 in rat
microglia, without toxicity [40]. Podonut prevalence was
not reduced by 100 μM spermine; it remained at 9.9 ±
2.0% of cells (Figure 4F,G). This provides evidence
against non-specific effects or toxicity of spermine. To-
gether, these results show that podosomes require Ca2+
entry, most likely through CRAC channels.
CRAC current is produced by the pore-forming sub-
unit, Orai1, and requires transient interaction with
STIM1, a Ca2+ sensor protein that is primarily localized
to the endoplasmic reticulum (ER) membrane (recently
reviewed in [44]). Orai1 immunoreactivity was highly
enriched in podonuts and in the core of individual podo-
somes, where it co-localized with Arp2 (Figure 5A).
[Note that antigen retrieval was necessary for Orai1
staining; see Methods.] As expected for an ER-associated
protein, STIM1 was enriched near the nucleus, and was
wide-spread throughout the cell (Figure 5B). STIM1 was
also prevalent in the podonut, near the podosome ring
component, vinculin. High-magnification images show a
close association between STIM1 and vinculin, with
some co-localization in podosome rings.
An earlier study over-expressed TRPM7 in the N1E-115
neuroblastoma cell line, and showed that it induced
podosomes and was present in them [45]. In contrast,
in microglia, block of native TRPM7 channels with
spermine had no effect (Figure 4) and the channel was
not enriched in podonuts (Figure 6). Microtubules regu-
late podosome dynamics and localization in monocytic
cells [46]. Thus, we asked whether the wide-spread, punc-
tate TRPM7 staining was associated with α-tubulin: it was
not. (Other channels that were not enriched in microglial
podosomes (not shown) were TRPC3 and SK4.)
Microglia migration and invasion involve Orai1/CRAC
and SK3 channels
Podosomes have dual roles in degrading extracellular
matrix molecules and regulating cell migration (see
Introduction). Therefore, we next tested whether block-
ing the ion channels we found in podosomes inhibits
migration and substrate degradation by microglia. Three
inhibitors of store-operated Ca2+ entry (Gd3+, 2-APB,
BTP2) were used in 24 hr assays at the concentrations
found to inhibit podosome/podonut formation (see
Figure 4). Spermine, which did not inhibit podonut for-
mation, could not be tested because it was toxic in these
longer-term assays. All three Ca2+-channel blockers
reduced three-dimensional transmigration through open
8-μm diameter holes in the filters of Transwell™ cham-
bers. The reductions were 71% by Gd3+, 86% by 2-APB,
68% by BTP2 (Figure 7A) and, as discussed above, this
pharmacology implicates CRAC channels.
To test the role of SK3 channels, we used the gating
modulator, NS8593. This inhibitor shifts the Ca2+ de-
pendence of opening of SK1, SK2 and SK3 (KCa2.1,
KCa2,2 and KCa2.3) channels but does not affect the
KCa3.1/SK4 channel [47]. The reported Kd values are
< 100 nM, but because its efficacy is Ca2+ dependent, we
used it at 7 μM to ensure that it fully inhibits SK1, SK2
and SK3. We previously reported lack of activity and
contributions of SK1 and SK2 in rat microglia [24,48];
(See figure on previous page.)
Figure 1 The small-conductance Ca2+-activated K+ channel, SK3, is expressed in podosomes of rat microglia. (A) Live imaging: Migrating
microglia have a lamellum at the leading edge (see arrows). Scale bars: 40 μm in A, B, C, E. (B) SK3 is prevalent in a large ring within many
lamellae (arrows). Microglia were labeled with tomato lectin (green), anti-SK3 antibody (red), nuclear stain, DAPI (blue throughout). (C) SK3-labeled
rings (red) co-label for F-actin (green; Alexa Fluor™ 488-conjugated phalloidin). Color-separated images are at right. (D) The large SK3 ring
comprises many small punctae containing the podosome ring component, talin (green). High-magnification, deconvolved images (right; boxed
areas) show tiny SK3 punctae (<1 μm diameter) surrounded by talin. Scale bars, 5 μm (left), 1 μm (middle, right). (E) A cell-sized area of
fibronectin degradation, seen as loss of Alexa Fluor™ 488 staining (green), co-localized with enriched SK3 staining (red). (F) Co-localization
(magenta) of SK3 (red) and F-actin (Alexa Fluor™ 488-conjugated phalloidin, false-colored blue) in a ‘podonut’. Scale bar, 5 μm. Right: higher-
magnification, merged and color-separated images of the boxed region showing SK3 + F-actin (merged; magenta), SK3 (red) and Alexa Fluor™
488-conjugated fibronectin (green). Note the many tiny punctae of F-actin and SK3 staining (podosomes) and similar-sized punctae of fibronectin
degradation (some examples shown by arrows). Scale bars, 1 μm.
Siddiqui et al. Journal of Neuroinflammation 2012, 9:250 Page 7 of 16
http://www.jneuroinflammation.com/content/9/1/250
thus, we conclude that any effects of NS8593 are
through SK3. NS8593 did not reduce microglia trans-
migration through open holes; that is, it was 115 ±
15% of the control value. This result rules out SK3
(and SK1, SK2) in this simple migration assay, and
provides evidence against non-specific effects or to-
xicity of NS8593.
Migration in two-dimensions was examined in a
scratch wound assay, in which microglia in the center of
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Figure 2 Calmodulin (CaM) is expressed in microglia podosomes. (A) A Western blot for CaM shows a strong band of the expected
molecular weight (approximately 17 kDa) for the positive control (left lane; 50 ng recombinant human CaM protein) and in lysates from
untreated cultured rat microglia (right lane). The (B) CaM is enriched in the podonut of lamella-bearing migrating cells. Non-deconvolved image
shows a cell stained with the microglia marker, tomato lectin (TL, green), the nuclear marker, DAPI (blue), and CaM (red), which is isolated in the
color-separated image at the right. Scale bar, 20 μm. (C) A deconvolved image of a podonut in a microglia lamellum, which shows enriched
staining for CaM (red) and the podosome ring marker, talin (green). Scale bar, 5 μm. (D) A high-resolution, deconvolved image from a podonut
ring shows CaM (red) within and surrounding the core, which is labeled with Arp2 (green). (Note: A mouse monoclonal anti-CaM antibody was
used.) Scale bar, 2 μm. Lower panel: Two podosomes are shown at higher magnification; one with extensive, diffuse CaM staining surrounding
Arp2. Scale bar, 1 μm. (E) CaM (green) and SK3 (red) co-localize in podonuts within the lamellae (nuclei are labeled with DAPI, blue). Color-
separated images at the right. Scale bars, 40 μm.
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coverslip. Unlike transmigration, the scratch wound likely
involves matrix molecules secreted by microglia and
chemotactic factors released by the damaged cells. Migra-
tion into the scratch wound was inhibited by the CRAC
channel blockers: 59% by Gd3+, 62% by 2-APB, and 54%
by BTP2 (Figure 7B). The scratch-wound assay was also
useful for examining the cell morphology. Many cells con-
tinued to express lamellae after BTP2 treatment. The SK3
blocker, NS8593, was not tested in the scratch wound
because it did not affect transmigration.
Finally, microglial invasion to the underside of Bio-
Coat™ Invasion chambers was examined. Invasion
requires both migration and degradation of the base-
ment membrane component, Matrigel™ that covers the
filter holes. Given that the CRAC-channel blockers
reduced migration, it is not surprising that invasion was
also inhibited; that is, 45% by Gd3+, 80% by 2-APB, and
88% by BTP2. More notable was that invasion was
reduced 62% by the SK3 inhibitor, NS8593 (Figure 7C).
Results in Figure 7 support the hypothesis that store-
operated Ca2+ channels contribute to microglia migration
and substrate degradation/invasion. The pharmacology
suggests that the underlying channel is Orai1/CRAC.
Further information can be gleaned by comparing the
drug efficacy in transmigration (open holes) versus in-
vasion (Matrigel™-covered holes) assays. The CRAC
channel blocker, BTP2, was more effective in inhibi-
ting invasion (by 88%) than transmigration (by 68%).
The SK3 inhibitor greatly reduced invasion but did not
affect microglia migration. Together, these differences
suggest a crucial role for both CRAC and SK3 channels in
substrate degradation.
Discussion
Podosomes are tiny, multi-molecular structures with two
key properties that can aid in cell migration through tis-
sue. They provide anchorage and traction mediated by
attachment to the ECM, and localized ECM degradation.
Podosomes are distinguished by having a two-part archi-
tecture. The F-actin-rich core is surrounded by a ring
containing integrins and adhesion-plaque proteins, in-
cluding talin, vinculin and paxillin [49-51]. We recently
discovered that the lamellae of migrating microglia con-
tain many podosomes, often arranged into a large ring
that we called a ‘podonut’ [10]. Individual podosomes
were identified as tiny (< 1 μm diameter) punctae with a
Iba1 vimentin DAPIA
talinIba1mergeC
F-actin   Iba1B
Figure 3 The microglia marker Iba1 is enriched in podonuts and podosomes. All panels show high-resolution, deconvolved images. (A).
Representative microglia showing strong Iba1 immunoreactivity (red) in the lamellar ring. Vimentin immunoreactivity (green) is also shown and
nuclei are labeled with DAPI (blue). Scale bar, 20 μm. (B) A microglial cell stained for Iba1 (red) and the podosome core marker, F-actin
(phalloidin; green). Scale bar, 5 μm. (C) Merged and color-separated images immunostained for Iba1 (green) and the podosome ring marker, talin
(red). Scale bar, 5 μm. C’: High-magnification images of talin and Iba1 in individual podosomes. Scale bar, 1 μm.
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core with F-actin and its nucleator, Arp2/3 that is sur-
rounded by a ring of talin. Microglia with podosomes
degraded the ECM component, fibronectin. This was
seen as a loss of fluorescence in cell-sized patches at low
magnification, and as podosome-sized punctae (approxi-
mately 1 μm) at high magnification. The present study
contributes several novel findings concerning podosome
structure and regulation.
Podosomes are highly dynamic and continually assem-
ble, mature and disassemble [7,8]. There is limited infor-
mation about processes regulating their rapid turnover.
Podosomes in normal cells and invadopodia in cancer
cells form only after cell adhesion. A key initiating factor
is thought to be cell attachment to the substrate through
integrins [9,51] but this is not sufficient. Of note,
myeloid-lineage cells (including our observations on
microglia) are apparently unique in spontaneously form-
ing podosomes upon cell attachment. While short-lived,
podosome stability involves regulation of the actin cyto-
skeleton [52,53]. The podosome core contains many
actin-regulating molecules. These include actin nuclea-
tors (Arp2/3 complex, formins), binding proteins (coro-
nin, tropomyosin), filament crosslinkers (caldesmon,
α-actinin) and polymerization activators (cortactin,
WASp and its regulators) [8,9,50]. In addition, activation
of integrins and receptor tyrosine kinases can induce
intracellular cascades involving c-Src, protein kinase C
and Rho- GTPases [11]. Several components of podo-
somes (and invadopodia) are regulated by tyrosine kin-
ase signaling [51,54]. Thus, it is not surprising that
phosphotyrosine residues are highly enriched in podo-
somes, including those in microglia [10].
Initially, we addressed the role of Ca2+ entry based on
evidence that Ca2+ regulates cell migration and cell-
substrate adhesions [12,13]. For instance, in human
breast cancer cells, turnover of focal adhesions was dis-
rupted by reducing external Ca2+ [55]. That study also
showed that substrate adhesion and migration were
impaired by the drug, SKF96365, which blocks several
Ca2+-permeable channels, including CRAC. Migrating
BTP2ED 2-APB
controlA no Ca2+B Gd 3+C
spermineF
G
























Figure 4 Podonut (podosome) formation requires Ca2+ entry, likely through Orai1/CRAC channels. (A-F). Microglia were fixed and stained
for F-actin (phalloidin; green), talin (red), and the nuclear stain, DAPI (blue) after 30 min (37°C) incubation in: standard bath (control, (A)), Ca2+-free
bath solution containing EGTA (B), 5 μM gadolinium (Gd3+, (C)), 50 μM 2-APB (D), 10 μM BTP2 (E) or 100 μM spermine (F). Scale bars, 20 μm. G.
Percentage of microglia expressing podonuts under each condition. Cells were fixed after 30 min treatment. Podonuts were counted from three
random fields on each immunostained cover slip, and averaged for cultures prepared from the number of rats indicated on each bar. Results are
expressed as mean ± SEM, and ***P <0.001 indicates differences from cells in standard bath (control).
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cells maintain a descending intracellular Ca2+ gradient
from the trailing uropod to the leading lamellum [13,56].
Brief, localized Ca2+ rises (Ca2+ flickers) in lamellipodia
can aid cell steering [57]. For microglia, we found that
Ca2+ influx was required for formation of podosomes
(and podonuts). The pharmacological profile implicates
CRAC channels in podosome formation, microglia
migration into a scratch wound, transmigration through
open pores, and invasion through Matrigel™. Thus, it is
notable that the core of individual podosomes contained
Orai1, which is the pore-forming subunit of CRAC [58].
CRAC channels open when Orai1 interacts with the ER-
molecule, STIM1, which is oligomerized following deple-
tion of intracellular Ca2+ stores (recently reviewed in
[44]). Oligomerization is rapidly reversed (approximately
2 min) when stores are replenished, and therefore the
STIM1-Orai1 interaction is transient. Podosomes are
also highly dynamic, with lifetimes as short as 2 min
[8,11]. Despite both processes being short-lived, we
found a close association of STIM1 with podosomes,
and some clear co-localization in the podosome ring.
Although it would be interesting to know if podosomes
transiently interact with functional CRAC channels in
response to localized depletion of Ca2+ stores, it will be
difficult to study such transient interactions.
Previous evidence linking podosomes to specific routes
of Ca2+ entry is limited. Information derives mainly from
over-expression studies and is often conflicting. Podo-
some formation in a neuroblastoma cell line was









B’ STIM1 DAPI vinculin   DAPI merge
Orai1 Arp2 merge
Figure 5 Microglial podosomes are enriched in the CRAC/Orai1 channel and closely associated with STIM1. All panels show high-
resolution, deconvolved images. (A) The podonut region of a representative microglial cell is stained for Orai1 (green) and the podosome core
marker, Arp2 (red); merged image is at the right. Scale bar, 5 μm. (A’) High-magnification images from the boxed region show strong co-
localization of Orai1 and Arp2 in podosome cores. Scale bar, 1 μm. (B) Color-separated and merged images of a microglial cell stained for STIM1
(green), vinculin (red), and the nuclear stain, DAPI (blue). Note the vinculin enrichment in the podonut. Scale bar, 5 μm. (B’) High-magnification
images from a different cell show proximity of STIM1 and vinculin, and several examples of co-localization (arrows). Scale bar, 1 μm.
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-permeable channel, TRPM7 [45], and is consistent with
a dependence on intracellular Ca2+. Another study
addressed TRPM7 but did not examine podosomes [57].
Having found that TRPM7 produced Ca2+ flicker activity
and was stretch-activated, the authors proposed that this
channel responds to cell adhesion, traction and migration.
We previously demonstrated robust expression of native
TRPM7 channels in primary rat microglia [17]. In micro-
glia, TRPM7 was not stretch-activated, and instead pro-
duced a large current under a wide range of activation
conditions [40]. Here, we show that TRPM7 was not
enriched in podosomes, and that blocking it did not affect
podosome formation. There are also conflicting data
regarding the role of Ca2+ in podosome formation. Two
earlier studies found that elevating intracellular Ca2+
reduced podosome numbers, but direct comparisons are
difficult. One study was in a macrophage cell line trans-
fected with the Ca2+-permeable channel, TRP Vanilloid 2
[59]. The second was in chicken osteoclasts under several
conditions that raised intracellular Ca2+ [60], including
high extracellular K+ or activators of voltage-gated Ca2+
channels. Because microglia lack voltage-gated Ca2+ cur-
rents [3,61], this finding is not expected to translate.
We examined subcellular localization of the Ca2+-acti-
vated K+ channel, SK3, because of our previous findings
that SK3 was increased in activated rat microglia in vivo
and regulated their classical activation in vitro [24]. We
surmised that SK3 likely acts by maintaining a driving
force for Ca2+ entry through Orai1/CRAC channels. No
previous reports have linked SK3 channels to podo-
somes. Here, we found that SK3 was highly enriched in
the podosome core. Importantly, its accessory molecule,
CaM, was present both within and around the podo-
somes. This is significant because the Ca2+ sensitivity of
SK channel gating is conferred by CaM, which is bound
to the channel’s carboxy-terminus [21,22]. SK channels
open after Ca2+ binds to CaM [62]. Here, we found that
the SK3 channel inhibitor, NS8593, did not affect migra-
tion through open holes but dramatically reduced micro-
glia invasion through Matrigel™. Thus, we conclude that
SK3 is involved in matrix degradation. SK3 has been
implicated in migration of some cancer cells. In one
study, an SK3-dependent membrane hyperpolarization
increased the motility of melanoma cells [63]. In an-
other, SK3 was expressed in tumor breast biopsies and a
highly metastasizing mammary cancer cell line, but not
TRPM7F-actinB
-tubulinA TRPM7 merge
Figure 6 Microglial podosomes are not enriched for the TRPM7 channel. All panels show high-resolution, deconvolved images. (A)
Color-separated and merged images of a microglial cell stained for the TRPM7 channel (red) and α-tubulin (green). (B) Microglia stained for
TRPM7 (red) and the podosome core marker, F-actin (phalloidin, green). Scale bars, 5 μm.
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in non-tumor breast tissue [12]. The latter study showed
that SK3 blockers inhibited migration, depolarized the
cell, and reduced intracellular Ca2+. We found one
report on non-cancer cells. SK3 was present in lamelli-
podia and filopodia of neural progenitor cells [64].
Pharmacological treatments implicated the channel in
formation of cellular projections, which are structures
used to explore the local environment, interact with
other cells and for migration.
Several other Ca2+-regulated molecules have been
identified in podosomes but mainly in transformed cells.
Caldesmon was found in Src-transformed fibroblasts
[65], calponin in the A7r5 smooth-muscle cell line [66],
gelsolin in Src-transformed fibroblasts and monocyte-
derived cells [67], and Pyk2 in the MB1.8 osteoclast cell
line [68]. We found that microglial podosomes are
highly enriched in the Ca2+-binding molecule, Iba1,
which is a marker used to identify microglia and infil-
trating macrophages in the CNS [37,38]. Iba1 has not
previously been reported in podosomes or invadopodia
but was of interest because it cross-links actin filaments
in a Ca2+ dependent manner [69]. Previously, Iba1 was
found in membrane ruffles and phagocytic cups of MG5
cells, a microglia cell line from p53-deficient mice [70].
However, Iba1 is not characteristic of all F-actin-rich
structures, and is not in filopodia or stress fibers [70].
We speculate that Iba1, which is in the core of micro-
glial podosomes, might stabilize them by cross-linking
F-actin. Other Ca2+-regulated actin cross-linking pro-
teins might play a similar role. For instance, α-actinin is
present in the podosome ring and core of macrophages,
osteoclasts, monocytes, and Src-transformed fibroblasts
[51,71-73].
Finally, we present a scheme to relate the literature on
podosome formation and roles to the present study and
our recent paper [10]. A key initiating factor in podo-
some formation is cell attachment to the substrate
through integrin binding. The subsequent signaling is
















































































Figure 7 Inhibition of microglia migration and invasion by
blocking CRAC or SK3 channels. Cultured rat microglial cells
were exposed for 24 hr to culture medium (MEM with 2%
serum) (control), with or without a channel blocker. CRAC
blockers were 5 μM Gd3+, 50 μM 2-APB, 10 μM BTP2. SK3 channels
were inhibited using 7 μM NS8593. (A) Cell transmigration across 8
μm-diameter holes in the filter of Transwell™ inserts. (B) Migration
into a scratch wound made in an essentially confluent layer of
microglia. Scale bar, 100 μm. (C) Invasion of microglia through filters
with Matrigel™-coated 8 μm-diameter holes (BioCoat Matrigel™
Invasion chambers). For each treatment, cell counts were tallied
from five random fields of view at 40× magnification
(transmigration, invasion) or 10× (scratch wound), and normalized to
control (untreated) microglia (100%, dashed line). The number of
individual cultures used is indicated on each bar. ***P < 0.001.
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and activation of substrates that include caveolin-1
[74,75] and Tks5 [76,77]. Phosphorylated Tks5 can act
as an organizer, recruiting other proteins, including
Nox1 [78], which is an enzyme that generates reactive
oxygen species. We recently showed that Tks5 and
Nox1 are constituents of microglial podosomes [10]. Src
can activate PLCγ [79] and release soluble inositol-1,4,5-
triphosphate (IP3), which evokes depletion of Ca
2+
stores. This is followed in some cell types by interaction
of STIM1 with Orai1 and activation of CRAC channels.
We previously showed that store depletion activates
CRAC currents in rat microglia [17]. Here, we show that
Orai1 and STIM1 are both present in and around micro-
glia podosomes. Ca2+ influx, most likely through CRAC
channels, regulated microglia podosome formation, mi-
gration and invasion through Matrigel™. Invasion also
required SK3 channels, which we discovered were
present in podosomes, along with their gating molecule,
CaM. We propose a working model in which localized
Ca2+ elevation caused by CRAC channels (Orai1 +
STIM1) activates Ca2+-dependent SK3 channels. The
resulting K+ efflux is expected to hyperpolarize the
membrane and help maintain a driving force for Ca2+
entry. Ca2+ entry is then expected to regulate multiple
downstream effector molecules that contribute to cell
migration.
Conclusions
The expression of podosomes in microglia has broad
implications. To carry out their functions, microglia
must migrate within the brain parenchyma. This
requires locally restricted ECM degradation, but without
damaging brain cells. Podosomes might help microglia
migrate in the developing brain, and after damage or in
disease states when there is inflammation and matrix re-
modeling. These unique structures contain several mole-
cules that suggest they are a hub for localized Ca2+
signaling to regulate both adhesion and ECM substrate
degradation. In microglia, Ca2+ entry regulated podo-
some formation, migration and invasion. The podo-
somes contain Orai1, STIM1, and several Ca2+
responsive proteins: SK3, CaM and Iba1. In future,
means of selectively targeting podosomes will be needed
in order to determine if these structures are crucial for
microglial migration and invasion through the brain.
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